OWC Pharmaceutical Research Corp.

Common Stock SEC Reporting - Current
Contact Info
  • 30 Shacham Street
  • P.O.B. 8324
  • Petach-Tikva 4918103
  • Israel

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001431934
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 2008
Employees 6 a/o Feb 25, 2016
Company Officers/Contacts
Mordechai Bignitz CEO, President
Alon Sinai COO
Yehuda Baruch Chief Scientific Officer, Director, R&D
Richard Rubin Counsel
Company Directors
Mordechai Bignitz Chairman
Service Providers
Accounting/Auditing Firm
Fahn Kanne & Co.
23 Menachem Begin St.
Levenstein Tower
24th floor
Tel-Aviv, 66184
Grant Thornton
Securities Counsel
Thomas J. Craft, Jr. Esq.
5420 North Ocean Drive
Ste. 2102
Singer Island, FL, 33404
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=Dynamic Applications Corp. until 1-2015
OWCP Security Details
Share Structure
Market Value1 $95,364,501 a/o Jun 23, 2017
Authorized Shares 500,000,000 a/o Jun 14, 2017
Outstanding Shares 146,022,694 a/o Jun 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 118,240,011 a/o Jun 12, 2017
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 160 a/o Jun 12, 2017
Short Selling Data
Short Interest 708,584 (-21.6%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security